A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Chelsea Manning will be freed in five months after President Obama reduced her remaining prison sentence for leaking government documents.
Staff working in sterilisation and disinfection units at Abertawe Bro Morgannwg University Health Board hospitals will go on strike over pay
Carwyn Jones has told AMs about a phone call with Theresa May before her Brexit speech. He also said he fears for Welsh ports post-Brexit.